Tradestie Institutional Equity Comparison Engine

EDIT vs CAPR โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CAPR Overall Edge

CAPR Captures Institutional Edge (4โ€“0 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Capricor Therapeutics Inc (CAPR) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, EDIT trades at N/M Forward P/E with -167.0% operating margin (+37.4% YoY revenue) versus CAPR at 78.7x Forward P/E and 0.0% operating margin (-7.9% YoY). In options structure, EDIT sits in BREAKDOWN (38th %ile IV; Dealer Gamma Walls on Pro) against CAPR sits in CONSOLIDATION (89th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner CAPR
EDIT N/M vs CAPR 78.7x Fwd P/E
Growth & Margin Winner CAPR
Op Margin -167.0% vs 0.0% ยท YoY +37.4% vs -7.9%
Momentum & Technical Winner CAPR
1Y -25.0% vs +44.3% ยท 52W Pos 11% vs 15%
Options & Structure Winner CAPR
BREAKDOWN (38th %ile IV) vs CONSOLIDATION (89th %ile IV)
EDIT NASDAQ
Editas Medicine, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$1.91
-12.21% 1D
Market Cap $336.5M
1M Return -18.94%
1Y Return -25.0%
Forward P/E N/M
Unified AI Score
51.6 / 100 HOLD
Tech 40.0 Fund 54.0 Flow 69.0 Mom 60.0
CAPR NASDAQ
Capricor Therapeutics Inc
Pharmaceutical Preparations
$8.47
-11.12% 1D
Market Cap $595.4M
1M Return +26.23%
1Y Return +44.29%
Forward P/E 78.7x
Unified AI Score
28.0 / 100 SELL
Tech 50.0 Fund 37.0 Flow 68.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: EDIT -25.0% CAPR +44.29% Spread: +71.79 pp (CAPR Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period EDIT Revenue CAPR Revenue EDIT Op. Margin CAPR Op. Margin Margin Edge
FY2018 $30M $0M -356.1% -917.0% EDIT
FY2019 $20M $0M -686.4% -769.5% EDIT
FY2020 $90M $0M -148.6% -4412.6% EDIT
FY2021 $30M $0M -756.1% -8549.9% EDIT
FY2022 $20M $0M -1146.3% -1163.9% EDIT
FY2023 $80M $30M -216.6% -95.6% CAPR
FY2024 $30M $20M -777.2% -191.1% CAPR
FY2025 $40M N/A -394.9% N/A EDIT

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: EDIT (3) vs CAPR (7)
Institutional Metric EDIT CAPR Criterion Row Winner
Market Capitalization Scale $336.5M $595.4M Larger Scale CAPR
Trailing P/E Ratio Valuation N/M 78.7x Lower Multiple CAPR
Forward P/E Ratio Valuation N/M 78.7x Lower Multiple CAPR
Revenue Growth (YoY) Growth +37.4% -7.9% Higher Growth EDIT
Operating Margin (TTM) Profitability -167.0% 0.0% Higher Margin CAPR
Net Profit Margin Profitability -144.9% 0.0% Higher Margin CAPR
Return on Equity (ROE) Capital Efficiency -147.4% -100.5% Higher ROE CAPR
52-Week Range Position Momentum 11% ($2โ€“$4) 15% ($3โ€“$40) Stronger Trend CAPR
Beta / 30D Volatility Risk Regime 2.32ฮฒ ยท 102% Vol 1.52ฮฒ ยท 152% Vol Lower Realized Risk EDIT
Unified Institutional Score Composite Signal 51.6 / 100 (HOLD) 28.0 / 100 (SELL) Higher Composite EDIT

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full EDIT vs CAPR Buy Guide
EDIT BREAKDOWN
146d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 38th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live EDIT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CAPR CONSOLIDATION
56d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 89th %ile
IV Regime Extreme (>80th %ile)
Live CAPR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither EDIT nor CAPR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.